These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 12634236

  • 1. Oral corticosteroid prescribing in women over 50, use of fracture prevention therapy, and bone densitometry service.
    Chantler IW, Davie MW, Evans SF, Rees JS.
    Ann Rheum Dis; 2003 Apr; 62(4):350-2. PubMed ID: 12634236
    [Abstract] [Full Text] [Related]

  • 2. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
    Segaud N, Legroux I, Hazzan M, Noel C, Cortet B.
    Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice.
    Gudbjornsson B, Juliusson UI, Gudjonsson FV.
    Ann Rheum Dis; 2002 Jan; 61(1):32-6. PubMed ID: 11779755
    [Abstract] [Full Text] [Related]

  • 4. Initiation of osteoporosis treatment after bone mineral density testing.
    Pressman A, Forsyth B, Ettinger B, Tosteson AN.
    Osteoporos Int; 2001 Jan; 12(5):337-42. PubMed ID: 11444079
    [Abstract] [Full Text] [Related]

  • 5. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S, Dragomir A, Desgagné A, Blais L, Rossignol M, Blouin J, Moride Y, Ste-Marie LG, Fernandès JC.
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [Abstract] [Full Text] [Related]

  • 6. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study.
    Walsh LJ, Wong CA, Pringle M, Tattersfield AE.
    BMJ; 1996 Aug 10; 313(7053):344-6. PubMed ID: 8760745
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study.
    Rossini M, Viapiana O, Vitiello M, Malavolta N, La Montagna G, Maddali Bongi S, Di Munno O, Nuti R, Manzini CU, Ferri C, Bogliolo L, Mathieu A, Cantatore F, Del Puente A, Muratore M, Grassi W, Frediani B, Saviola G, Delvino P, Mirone L, Ferraccioli G, Tripi G, Piazza I, Gatti D.
    Reumatismo; 2017 May 22; 69(1):30-39. PubMed ID: 28535619
    [Abstract] [Full Text] [Related]

  • 8. Using computers to identify non-compliant people at increased risk of osteoporotic fractures in general practice: a cross-sectional study.
    de Lusignan S, van Vlymen J, Hague N, Dhoul N.
    Osteoporos Int; 2006 Dec 22; 17(12):1808-14. PubMed ID: 16932873
    [Abstract] [Full Text] [Related]

  • 9. Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.
    Ito K, Blinder VS, Elkin EB.
    J Clin Oncol; 2012 May 01; 30(13):1468-75. PubMed ID: 22370313
    [Abstract] [Full Text] [Related]

  • 10. The impact of oral corticosteroid use on bone mineral density and vertebral fracture.
    Walsh LJ, Lewis SA, Wong CA, Cooper S, Oborne J, Cawte SA, Harrison T, Green DJ, Pringle M, Hubbard R, Tattersfield AE.
    Am J Respir Crit Care Med; 2002 Sep 01; 166(5):691-5. PubMed ID: 12204867
    [Abstract] [Full Text] [Related]

  • 11. [Glucocorticoid-induced osteoporosis].
    Braun J, Sieper J.
    Orthopade; 2001 Jul 01; 30(7):444-50. PubMed ID: 11515182
    [Abstract] [Full Text] [Related]

  • 12. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J.
    Arthritis Rheum; 2002 Dec 01; 46(12):3136-42. PubMed ID: 12483716
    [Abstract] [Full Text] [Related]

  • 13. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr 01; 17(94):68-72. PubMed ID: 18536138
    [Abstract] [Full Text] [Related]

  • 14. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Koh JH, Myong JP, Yoo J, Lim YW, Lee J, Kwok SK, Park SH, Ju JH.
    Osteoporos Int; 2017 Nov 01; 28(11):3251-3259. PubMed ID: 28748389
    [Abstract] [Full Text] [Related]

  • 15. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
    Yosipovitch G, Hoon TS, Leok GC.
    Arch Dermatol; 2001 Apr 01; 137(4):477-81. PubMed ID: 11295929
    [Abstract] [Full Text] [Related]

  • 16. Fracture prevention in elderly women: treatment of osteoporosis is one approach, together with physical exercise and fall prevention.
    Prescrire Int; 1998 Oct 01; 7(37):155-9. PubMed ID: 10915424
    [Abstract] [Full Text] [Related]

  • 17. Glucocorticoid-Induced Osteoporosis Prevention in Polymyalgia Rheumatica Patients.
    Swami T, Molloy C.
    Ir Med J; 2020 Mar 13; 113(3):36. PubMed ID: 32815678
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The association between corticosteroid use and development of fractures among IBD patients in a population-based database.
    Bernstein CN, Blanchard JF, Metge C, Yogendran M.
    Am J Gastroenterol; 2003 Aug 13; 98(8):1797-801. PubMed ID: 12907335
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.